Evidence map›Paper›PMID 27742545›Full record

ArticleImmunity2016

Leishmania Uses Mincle to Target an Inhibitory ITAM Signaling Pathway in Dendritic Cells that Dampens Adaptive Immunity to Infection.

Salvador Iborra, María Martínez-López, Francisco J Cueto, Ruth Conde-Garrosa, Carlos Del Fresno, Helena M Izquierdo, Clare L Abram, Daiki Mori, Yolanda Campos-Martín, Rosa María Reguera and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Immunity, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 92 citations in OpenAlex.

  1. Review
  2. Synthetic Ligands of Myeloid C-Type Lectin Receptors.Chembiochem : a European journal of chemical biology · 2026
    Review
  3. Article
  4. Infection and immunity · 2026
    Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. iScience · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 3 countries.

Salvador IborraImmunobiology Laboratory, Fundación Centro Nacional de Investigaciones Cardiovasculares "Carlos III" (CNIC), Melchor Fernández Almagro 3, Madrid 28029, Spain; Departamento de Biología Molecular Centro de Biología Molecular Severo Ochoa (CSIC-UAM), Nicolás Cabrera 1, Universidad Autónoma de Madrid, Madrid 28049, Spain. Electronic address: siborra@cnic.es.
María Martínez-LópezImmunobiology Laboratory, Fundación Centro Nacional de Investigaciones Cardiovasculares "Carlos III" (CNIC), Melchor Fernández Almagro 3, Madrid 28029, Spain.
Francisco J CuetoImmunobiology Laboratory, Fundación Centro Nacional de Investigaciones Cardiovasculares "Carlos III" (CNIC), Melchor Fernández Almagro 3, Madrid 28029, Spain; Department of Biochemistry, Faculty of Medicine, Universidad Autónoma de Madrid, Calle Arzobispo Morcillo 4, Madrid 28029, Spain.
Ruth Conde-GarrosaImmunobiology Laboratory, Fundación Centro Nacional de Investigaciones Cardiovasculares "Carlos III" (CNIC), Melchor Fernández Almagro 3, Madrid 28029, Spain.
Carlos Del FresnoImmunobiology Laboratory, Fundación Centro Nacional de Investigaciones Cardiovasculares "Carlos III" (CNIC), Melchor Fernández Almagro 3, Madrid 28029, Spain.
Helena M IzquierdoImmunobiology Laboratory, Fundación Centro Nacional de Investigaciones Cardiovasculares "Carlos III" (CNIC), Melchor Fernández Almagro 3, Madrid 28029, Spain.
Clare L AbramDepartment of Laboratory Medicine, University of California, San Francisco, San Francisco, CA 94143, USA.
Daiki MoriDivision of Molecular Immunology, Medical Institute of Bioregulation, Kyushu University, Fukuoka 812-8582, Japan.
Yolanda Campos-MartínServicio Anatomía Patológica, Hospital Virgen de la Salud, Avenida de Barber, 30, Toledo 45004, Spain.
Rosa María RegueraDepartamento de Ciencias Biomédicas, Universidad de León, Facultad de Veterinaria Campus de Vegazana s/n, León 24071, Spain.
Benjamin KempMedimmune, Granta Park, Cambridge, CB21 6GH, UK.
Sho YamasakiDivision of Molecular Immunology, Medical Institute of Bioregulation, Kyushu University, Fukuoka 812-8582, Japan.
Matthew J RobinsonMedimmune, Granta Park, Cambridge, CB21 6GH, UK.
Manuel SotoDepartamento de Biología Molecular Centro de Biología Molecular Severo Ochoa (CSIC-UAM), Nicolás Cabrera 1, Universidad Autónoma de Madrid, Madrid 28049, Spain.
Clifford A LowellDepartment of Laboratory Medicine, University of California, San Francisco, San Francisco, CA 94143, USA.
David SanchoImmunobiology Laboratory, Fundación Centro Nacional de Investigaciones Cardiovasculares "Carlos III" (CNIC), Melchor Fernández Almagro 3, Madrid 28029, Spain. Electronic address: dsancho@cnic.es.
Spanish National Centre for Cardiovascular Research · ESKyushu University · JPUniversidad Autónoma de Madrid · ESUniversity of California, San Francisco · USHospital Virgen de la Salud · ESUniversidad de León · ES

Funding

Mechanisms of Neutrophil ActivationR01AI065495 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LOWELL, CLIFFORD A · 2005 to 2017
$3.7M
Regulation of Innate Immune Signaling by Lyn KinaseR01AI113272 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LOWELL, CLIFFORD A · 2015 to 2019
$2.0M
European Research Council 260414NIAID NIH HHS R01 AI065495NIAID NIH HHS R01 AI113272
6 · The paper itself

Abstract

C-type lectin receptors sense a diversity of endogenous and exogenous ligands that may trigger differential responses. Here, we have found that human and mouse Mincle bind to a ligand released by Leishmania, a eukaryote parasite that evades an effective immune response. Mincle-deficient mice had milder dermal pathology and a tenth of the parasite burden compared to wild-type mice after Leishmania major intradermal ear infection. Mincle deficiency enhanced adaptive immunity against the parasite, correlating with increased activation, migration, and priming by Mincle-deficient dendritic cells (DCs). Leishmania triggered a Mincle-dependent inhibitory axis characterized by SHP1 coupling to the FcRγ chain. Selective loss of SHP1 in CD11c

Indexed as

Adaptive ImmunityAnimalsCD11c AntigenCell DifferentiationCell Line, TumorDendritic CellsImmunoreceptor Tyrosine-Based Activation MotifLectins, C-TypeLeishmania majorMembrane ProteinsMiceMice, Inbred C57BLMice, TransgenicProtein Tyrosine Phosphatase, Non-Receptor Type 6Receptors, FcSignal TransductionCD11c AntigenClecsf8 protein, mouseLectins, C-TypeMembrane ProteinsProtein Tyrosine Phosphatase, Non-Receptor Type 6Receptors, Fc

Identifiers

PMID27742545
PMCPMC5074365
OpenAlexW2530405675

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.